Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Micallef, MJ; Darmanin, S; Buhagiar, JA; Camilleri-Podesta, MT; Yamauchi, H; Kurimoto, M; Inglott, AS; Ellul-Micallef, R
   Interferon gamma induction in human melanoma cell/allogeneic leukocyte co-cultures is enhanced by interleukin 18 but drug resistant melanoma cells are poorer inducers of IFN-gamma
   INTERNATIONAL IMMUNOPHARMACOLOGY
   
   M.J. Micallef et al., "Interferon gamma induction in human melanoma cell/allogeneic leukocyte co-cultures is enhanced by interleukin 18 but drug resistant melanoma cells are poorer inducers of IFN-gamma", INT IMMUNO, 1(2), 2001, pp. 295-305
2. Liu, MIP; Hutson, JM
   Ontogeny of bladder agenesis in rats induced by adriamycin
   BJU INTERNATIONAL
   
   M.I.P. Liu e J.M. Hutson, "Ontogeny of bladder agenesis in rats induced by adriamycin", BJU INT, 87(6), 2001, pp. 556-561
3. Rekatas, CJ; Mai, SM; Crothers, M; Quinn, M; Collett, JH; Attwood, D; Heatley, F; Martini, L; Booth, C
   The effect of hydrophobe chemical structure and chain length on the solubilization of griseofulvin in aqueous micellar solutions of block copoly(oxyalkylene)s
   PHYSICAL CHEMISTRY CHEMICAL PHYSICS
   
   C.J. Rekatas et al., "The effect of hydrophobe chemical structure and chain length on the solubilization of griseofulvin in aqueous micellar solutions of block copoly(oxyalkylene)s", PHYS CHEM P, 3(21), 2001, pp. 4769-4773
4. Balestrieri, E; Zanier, R; Degrassi, F
   Molecular characterisation of camptothecin-induced mutations at the hprt locus in Chinese hamster cells
   MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS
   
   E. Balestrieri et al., "Molecular characterisation of camptothecin-induced mutations at the hprt locus in Chinese hamster cells", MUT RES-F M, 476(1-2), 2001, pp. 63-69
5. Eliasson, C; Loren, A; Murty, KVGK; Josefson, M; Kall, M; Abrahamsson, J; Abrahamsson, K
   Multivariate evaluation of doxorubicin surface-enhanced Raman spectra
   SPECTROCHIMICA ACTA PART A-MOLECULAR AND BIOMOLECULAR SPECTROSCOPY
   
   C. Eliasson et al., "Multivariate evaluation of doxorubicin surface-enhanced Raman spectra", SPECT ACT A, 57(9), 2001, pp. 1907-1915
6. Elsendoorn, TJ; Weijl, NI; Mithoe, S; Zwinderman, AH; Van Dam, F; De Zwart, FA; Tates, AD; Osanto, S
   Chemotherapy-induced chromosomal damage in peripheral blood lymphocytes ofcancer patients supplemented with antioxidants or placebo
   MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS
   
   T.J. Elsendoorn et al., "Chemotherapy-induced chromosomal damage in peripheral blood lymphocytes ofcancer patients supplemented with antioxidants or placebo", MUT RES-GTE, 498(1-2), 2001, pp. 145-158
7. Kostoryz, EL; Yourtee, DM
   Oxidative mutagenesis of doxorubicin-Fe(III) complex
   MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS
   
   E.L. Kostoryz e D.M. Yourtee, "Oxidative mutagenesis of doxorubicin-Fe(III) complex", MUT RES-GTE, 490(2), 2001, pp. 131-139
8. Harada, K; Bando, T; Yoshida, H; Sato, M
   Characteristics of antitumour activity of cepharanthin against a human adenosquamous cell carcinoma cell line
   ORAL ONCOLOGY
   
   K. Harada et al., "Characteristics of antitumour activity of cepharanthin against a human adenosquamous cell carcinoma cell line", ORAL ONCOL, 37(8), 2001, pp. 643-651
9. Allen, J; Thomson, JDR; Lewis, IJ; Gibbs, JL
   Mitral regurgitation after anthracycline treatment for childhood malignancy
   HEART
   
   J. Allen et al., "Mitral regurgitation after anthracycline treatment for childhood malignancy", HEART, 85(4), 2001, pp. 430-432
10. Takeuchi, H; Kojima, H; Yamamoto, H; Kawashima, Y
    Evaluation of the anti-tumour activity of liposomal doxorubicin coated with hydrophilic polymers in tumour-bearing mice
    STP PHARMA SCIENCES
    
    H. Takeuchi et al., "Evaluation of the anti-tumour activity of liposomal doxorubicin coated with hydrophilic polymers in tumour-bearing mice", STP PHARM S, 11(4), 2001, pp. 271-274
11. Gravis, G; Mousseau, M; Douillard, JY; Dorval, T; Fabbro, M; Escudier, B; Mignot, L; Viens, P
    Can interleukin-2 reverse anthracyclin chemoresistance in metastatic soft tissue sarcoma patients. Results of a prospective phase II clinical trial
    EUROPEAN CYTOKINE NETWORK
    
    G. Gravis et al., "Can interleukin-2 reverse anthracyclin chemoresistance in metastatic soft tissue sarcoma patients. Results of a prospective phase II clinical trial", EUR CYTOKIN, 12(2), 2001, pp. 239-243
12. Longhi, A; Fabbri, N; Donati, D; Capanna, R; Briccoli, A; Biagini, R; Bernini, G; Ferrari, S; Versari, M; Bacci, G
    Neoadjuvant chemotherapy for patients with synchronous multifocal osteosarcoma: Results in eleven cases
    JOURNAL OF CHEMOTHERAPY
    
    A. Longhi et al., "Neoadjuvant chemotherapy for patients with synchronous multifocal osteosarcoma: Results in eleven cases", J CHEMOTHER, 13(3), 2001, pp. 324-330
13. Tari, AM; Mehta, A; Lopez-Berestein, G
    Modulation of Akt activity by doxorubicin in breast cancer cells
    JOURNAL OF CHEMOTHERAPY
    
    A.M. Tari et al., "Modulation of Akt activity by doxorubicin in breast cancer cells", J CHEMOTHER, 13(3), 2001, pp. 334-336
14. Bacci, G; Ferrari, S; Longhi, A; Forni, C; Bertoni, F; Fabbri, N; Zavatta, M; Versari, M
    Neoadjuvant chemotherapy for high grade osteosarcoma of the extremities: Long-term results for patients treated according to the rizzoli IOR/OS-3b protocol
    JOURNAL OF CHEMOTHERAPY
    
    G. Bacci et al., "Neoadjuvant chemotherapy for high grade osteosarcoma of the extremities: Long-term results for patients treated according to the rizzoli IOR/OS-3b protocol", J CHEMOTHER, 13(1), 2001, pp. 93-99
15. Hayashi, S; Kano, E; Tsuji, K; Furukawa-Furuya, M; Yoshikawa, S; Hatashita, M; Matsumoto, H; Jin, ZH; Ohtsubo, T; Kitai, R
    Modification of thermosensitivity and chemosensitivity induced by combinedtreatments with hyperthermia and adriamycin
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
    
    S. Hayashi et al., "Modification of thermosensitivity and chemosensitivity induced by combinedtreatments with hyperthermia and adriamycin", INT J MOL M, 8(4), 2001, pp. 417-422
16. Casares, S; Stan, AC; Bona, CA; Brumeanu, TD
    Antigen-specific downregulation of T cells by doxorubicin delivered through a recombinant MI-IC II-peptide chimera
    NATURE BIOTECHNOLOGY
    
    S. Casares et al., "Antigen-specific downregulation of T cells by doxorubicin delivered through a recombinant MI-IC II-peptide chimera", NAT BIOTECH, 19(2), 2001, pp. 142-147
17. Abraham, EH; Shrivastav, B; Salikhova, AY; Sterling, KM; Johnston, N; Guidotti, G; Scala, S; Litman, T; Chan, KC; Arceci, RJ; Steiglitz, K; Herscher, L; Okunieff, P
    Cellular and biophysical evidence for interactions between adenosine triphosphate and P-glycoprotein substrates: functional implications for adenosine triphosphate/drug cotransport in P-glycoprotein overexpressing tumor cells and in P-glycoprotein low-level expressing erythrocytes
    BLOOD CELLS MOLECULES AND DISEASES
    
    E.H. Abraham et al., "Cellular and biophysical evidence for interactions between adenosine triphosphate and P-glycoprotein substrates: functional implications for adenosine triphosphate/drug cotransport in P-glycoprotein overexpressing tumor cells and in P-glycoprotein low-level expressing erythrocytes", BL CELL M D, 27(1), 2001, pp. 181-200
18. Robinson, BW; Shewach, DS
    Radiosensitization by gemcitabine in p53 wild-type and mutant MCF-7 breastcarcinoma cell lines
    CLINICAL CANCER RESEARCH
    
    B.W. Robinson e D.S. Shewach, "Radiosensitization by gemcitabine in p53 wild-type and mutant MCF-7 breastcarcinoma cell lines", CLIN CANC R, 7(8), 2001, pp. 2581-2589
19. van Acker, FAA; Boven, E; Kramer, K; Haenen, GRMM; Bast, A; van der Vijgh, WJF
    Frederine, a new and promising protector against doxorubicin-induced cardiotoxicity
    CLINICAL CANCER RESEARCH
    
    F.A.A. van Acker et al., "Frederine, a new and promising protector against doxorubicin-induced cardiotoxicity", CLIN CANC R, 7(5), 2001, pp. 1378-1384
20. Miller, RA; Woodburn, KW; Fan, Q; Lee, I; Miles, D; Duran, G; Sikic, B; Magda, D
    Motexafin gadolinium: A redox active drug that enhances the efficacy of bleomycin and doxorubicin
    CLINICAL CANCER RESEARCH
    
    R.A. Miller et al., "Motexafin gadolinium: A redox active drug that enhances the efficacy of bleomycin and doxorubicin", CLIN CANC R, 7(10), 2001, pp. 3215-3221
21. El-Missiry, MA; Othman, AI; Amer, MA; El-Aziz, MAA
    Attenuation of the acute adriamycin-induced cardiac and hepatic oxidative toxicity by N-(2-mercaptopropionyl) glycine in rats
    FREE RADICAL RESEARCH
    
    M.A. El-Missiry et al., "Attenuation of the acute adriamycin-induced cardiac and hepatic oxidative toxicity by N-(2-mercaptopropionyl) glycine in rats", FREE RAD RE, 35(5), 2001, pp. 575-581
22. Rangan, GK; Wang, YP; Harris, DCH
    Induction of proteinuric chronic glomerular disease in the rat (Rattus norvegicus) by intracardiac injection of doxorubicin hydrochloride
    CONTEMPORARY TOPICS IN LABORATORY ANIMAL SCIENCE
    
    G.K. Rangan et al., "Induction of proteinuric chronic glomerular disease in the rat (Rattus norvegicus) by intracardiac injection of doxorubicin hydrochloride", CONT T LAB, 40(5), 2001, pp. 44-49
23. Teodori, E; Dei, S; Garnier-Suillerot, A; Quidu, P; Scapecchi, S; Budriesi, R
    Structure-activity relationship studies on the potent multidrug resistance(MDR) modulator 2-(3,4-dimethoxyphenyl)-2-(methylethyl)-5-[(anthr-9-yl)methylamino]pentanenitrile (MM 36)
    MEDICINAL CHEMISTRY RESEARCH
    
    E. Teodori et al., "Structure-activity relationship studies on the potent multidrug resistance(MDR) modulator 2-(3,4-dimethoxyphenyl)-2-(methylethyl)-5-[(anthr-9-yl)methylamino]pentanenitrile (MM 36)", MED CHEM RE, 10(9), 2001, pp. 563-576
24. Davidson, JM
    Experimental animal wound models
    WOUNDS-A COMPENDIUM OF CLINICAL RESEARCH AND PRACTICE
    
    J.M. Davidson, "Experimental animal wound models", WOUNDS, 13(1), 2001, pp. 9-23
25. Sayed-Ahmed, MM; Salman, TM; Gaballah, HE; El-Naga, SAA; Nicolai, R; Calvani, M
    Propionyl-L-carnitine as protector against adriamycin-induced cardiomyopathy
    PHARMACOLOGICAL RESEARCH
    
    M.M. Sayed-Ahmed et al., "Propionyl-L-carnitine as protector against adriamycin-induced cardiomyopathy", PHARMAC RES, 43(6), 2001, pp. 513-520
26. Saad, SY; Najjar, TA; Al-Rikabi, AC
    The preventive role of deferoxamine against acute doxorubicin-induced cardiac, renal and hepatic toxicity in rats
    PHARMACOLOGICAL RESEARCH
    
    S.Y. Saad et al., "The preventive role of deferoxamine against acute doxorubicin-induced cardiac, renal and hepatic toxicity in rats", PHARMAC RES, 43(3), 2001, pp. 211-218
27. Jeong, JH; Park, TG
    Novel polymer-DNA hybrid polymeric micelles composed of hydrophobic poly(D,L-lactic-co-glycolic acid) and hydrophilic oligonucleotides
    BIOCONJUGATE CHEMISTRY
    
    J.H. Jeong e T.G. Park, "Novel polymer-DNA hybrid polymeric micelles composed of hydrophobic poly(D,L-lactic-co-glycolic acid) and hydrophilic oligonucleotides", BIOCONJ CHE, 12(6), 2001, pp. 917-923
28. Enschede, SH; Shahidi, H; Venugopal, P; Riley, MB; Huang, RW; Jajeh, A; Preisler, HD; Gregory, SA
    Effectiveness of interferon-alfa and mid-cycle chemotherapy added to an anthracycline-based regimen in the treatment of aggressive non-Hodgkin's lymphoma
    LEUKEMIA & LYMPHOMA
    
    S.H. Enschede et al., "Effectiveness of interferon-alfa and mid-cycle chemotherapy added to an anthracycline-based regimen in the treatment of aggressive non-Hodgkin's lymphoma", LEUK LYMPH, 40(3-4), 2001, pp. 325-334
29. Rihova, B; Strohalm, J; Hoste, K; Jelinkova, M; Hovorka, O; Kovar, M; Plocova, D; Sirova, M; Stastny, M; Schacht, E; Ulbrich, K
    Immunoprotective therapy with targeted anticancer drugs
    MACROMOLECULAR SYMPOSIA
    
    B. Rihova et al., "Immunoprotective therapy with targeted anticancer drugs", MACRO SYMP, 172, 2001, pp. 21-28
30. Minko, T; Kopeckova, P; Kopecek, J
    Mechanisms of anticancer action of HPMA copolymer-bound doxorubicin
    MACROMOLECULAR SYMPOSIA
    
    T. Minko et al., "Mechanisms of anticancer action of HPMA copolymer-bound doxorubicin", MACRO SYMP, 172, 2001, pp. 35-47
31. Berrak, SG; Ewer, MS; Jaffe, N; Pearson, P; Ried, K; Zietz, HA; Benjamin, RS
    Doxorubicin cardiotoxicity in children: Reduced incidence of cardiac dysfunction associated with continuous-infusion schedules
    ONCOLOGY REPORTS
    
    S.G. Berrak et al., "Doxorubicin cardiotoxicity in children: Reduced incidence of cardiac dysfunction associated with continuous-infusion schedules", ONCOL REP, 8(3), 2001, pp. 611-614
32. Wang, BN; Wu, MF; Perchellet, EM; McIlvain, CJ; Sperfslage, BJ; Huang, XD; Tamura, M; Stephany, HA; Hua, DH; Perchellet, JP
    A synthetic triptycene bisquinone, which blocks nucleoside transport and induces DNA fragmentation, retains its cytotoxic efficacy in daunorubicin-resistant HL-60 cell lines
    INTERNATIONAL JOURNAL OF ONCOLOGY
    
    B.N. Wang et al., "A synthetic triptycene bisquinone, which blocks nucleoside transport and induces DNA fragmentation, retains its cytotoxic efficacy in daunorubicin-resistant HL-60 cell lines", INT J ONCOL, 19(6), 2001, pp. 1169-1178
33. Shimose, S; Sugita, T; Nitta, Y; Kubo, T; Ikuta, Y; Murakami, T
    Effect of thermosensitive liposomal doxorubicin with hyperthermia on primary tumor and lung metastases in hamster osteosarcoma
    INTERNATIONAL JOURNAL OF ONCOLOGY
    
    S. Shimose et al., "Effect of thermosensitive liposomal doxorubicin with hyperthermia on primary tumor and lung metastases in hamster osteosarcoma", INT J ONCOL, 19(3), 2001, pp. 585-589
34. Wu, XX; Kakehi, Y; Mizutani, Y; Lu, J; Terachi, T; Ogawa, O
    Activation of caspase-3 in renal cell carcinoma cells by anthracyclines or5-fluorouracil
    INTERNATIONAL JOURNAL OF ONCOLOGY
    
    X.X. Wu et al., "Activation of caspase-3 in renal cell carcinoma cells by anthracyclines or5-fluorouracil", INT J ONCOL, 19(1), 2001, pp. 19-24
35. Zagozdzon, R; Golab, J
    Immunomodulation by anticancer chemotherapy: More is not always better (review)
    INTERNATIONAL JOURNAL OF ONCOLOGY
    
    R. Zagozdzon e J. Golab, "Immunomodulation by anticancer chemotherapy: More is not always better (review)", INT J ONCOL, 18(2), 2001, pp. 417-424
36. Wapstra, FH; Navis, GJ; van Goor, H; van den Born, J; Berden, JHM; de Jong, PE; de Zeeuw, D
    ACE inhibition preserves heparan sulfate proteoglycans in the glomerular basement membrane of rats with established adriamycin nephropathy
    EXPERIMENTAL NEPHROLOGY
    
    F.H. Wapstra et al., "ACE inhibition preserves heparan sulfate proteoglycans in the glomerular basement membrane of rats with established adriamycin nephropathy", EXP NEPHROL, 9(1), 2001, pp. 21-27
37. Yang, H; Huang, YG; Zhang, XJ; Yang, FY
    Cardiolipin is essential for higher proton translocation activity of reconstituted F-o
    SCIENCE IN CHINA SERIES C-LIFE SCIENCES
    
    H. Yang et al., "Cardiolipin is essential for higher proton translocation activity of reconstituted F-o", SCI CHINA C, 44(2), 2001, pp. 146-155
38. Hu, JB; Huang, QQ; Li, QL
    Electrochemical behavior of adriamycin at a cobalt ion implantation modified electrode
    CHINESE SCIENCE BULLETIN
    
    J.B. Hu et al., "Electrochemical behavior of adriamycin at a cobalt ion implantation modified electrode", CHIN SCI B, 46(16), 2001, pp. 1355-1357
39. Ohkura, K; Hori, H
    Modification of cell response to insulin by membrane-acting agents in rat white adipocytes: Analysis of structural features by computational simulation
    BIOORGANIC & MEDICINAL CHEMISTRY
    
    K. Ohkura e H. Hori, "Modification of cell response to insulin by membrane-acting agents in rat white adipocytes: Analysis of structural features by computational simulation", BIO MED CH, 9(11), 2001, pp. 3023-3033
40. Batchelor, D
    Hair and cancer chemotherapy: consequences and nursing care - a literaturestudy
    EUROPEAN JOURNAL OF CANCER CARE
    
    D. Batchelor, "Hair and cancer chemotherapy: consequences and nursing care - a literaturestudy", EUR J CA C, 10(3), 2001, pp. 147-163
41. Verrill, M
    Anthracyclines in breast cancer: therapy and issues of toxicity
    BREAST
    
    M. Verrill, "Anthracyclines in breast cancer: therapy and issues of toxicity", BREAST, 10, 2001, pp. 8-15
42. Batist, G
    Improving the therapeutic index when using Myocet (TM) in the treatment ofmetastatic breast cancer
    BREAST
    
    G. Batist, "Improving the therapeutic index when using Myocet (TM) in the treatment ofmetastatic breast cancer", BREAST, 10, 2001, pp. 16-21
43. Marty, M
    Liposomal doxorubicin (Myocet (TM)) and conventional anthracyclines: a comparison
    BREAST
    
    M. Marty, "Liposomal doxorubicin (Myocet (TM)) and conventional anthracyclines: a comparison", BREAST, 10, 2001, pp. 28-33
44. Takahashi, H; Hashimoto, Y
    Formaldehyde-mediated modification of natural deoxyguanosine with amines: One-pot cyclization as a molecular model for genotoxicity
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
    
    H. Takahashi e Y. Hashimoto, "Formaldehyde-mediated modification of natural deoxyguanosine with amines: One-pot cyclization as a molecular model for genotoxicity", BIOORG MED, 11(5), 2001, pp. 729-731
45. Breitbart, E; Lomnitski, L; Nyska, A; Malik, Z; Bergman, M; Sofer, Y; Haseman, JK; Grossman, S
    Effects of water-soluble antioxidant from spinach, NAO, on doxorubicin-induced heart injury
    HUMAN & EXPERIMENTAL TOXICOLOGY
    
    E. Breitbart et al., "Effects of water-soluble antioxidant from spinach, NAO, on doxorubicin-induced heart injury", HUM EXP TOX, 20(7), 2001, pp. 337-345
46. Namer, M; Soler-Michel, P; Turpin, F; Chinet-Charrot, P; de Gislain, C; Pouillart, P; Delozier, T; Luporsi, E; Etienne, PL; Schraub, S; Eymard, JC; Serin, D; Ganem, G; Calais, G; Maillart, P; Colin, P; Trillet-Lenoir, V; Prevost, G; Tigaud, D; Clavere, P; Marti, P; Romieu, C; Wendling, JL
    Results of a phase III prospective, randomised trial, comparing mitoxantrone and vinorelbine (MV) in combination with standard FAC/FEC in front-line therapy of metastatic breast cancer
    EUROPEAN JOURNAL OF CANCER
    
    M. Namer et al., "Results of a phase III prospective, randomised trial, comparing mitoxantrone and vinorelbine (MV) in combination with standard FAC/FEC in front-line therapy of metastatic breast cancer", EUR J CANC, 37(9), 2001, pp. 1132-1140
47. Chakrabarti, KB; Hopewell, JW; Wilding, D; Plowman, PN
    Modification of doxorubicin-induced cardiotoxicity: effect of essential fatty acids and ICRF-187 (dexrazoxane)
    EUROPEAN JOURNAL OF CANCER
    
    K.B. Chakrabarti et al., "Modification of doxorubicin-induced cardiotoxicity: effect of essential fatty acids and ICRF-187 (dexrazoxane)", EUR J CANC, 37(11), 2001, pp. 1435-1442
48. Shiah, JG; Dvorak, M; Kopeckova, P; Sun, Y; Peterson, CM; Kopecek, J
    Biodistribution and antitumour efficacy of long-circulating N-(2-hydroxypropyl)methacrylamide copolymer-doxorubicin conjugates in nude mice
    EUROPEAN JOURNAL OF CANCER
    
    J.G. Shiah et al., "Biodistribution and antitumour efficacy of long-circulating N-(2-hydroxypropyl)methacrylamide copolymer-doxorubicin conjugates in nude mice", EUR J CANC, 37(1), 2001, pp. 131-139
49. Uchiyama-Kokubu, N; Watanabe, T
    Establishment and characterization of adriamycin-resistant human colorectal adenocarcinoma HCT-15 cell lines with multidrug resistance
    ANTI-CANCER DRUGS
    
    N. Uchiyama-Kokubu e T. Watanabe, "Establishment and characterization of adriamycin-resistant human colorectal adenocarcinoma HCT-15 cell lines with multidrug resistance", ANTI-CANC D, 12(9), 2001, pp. 769-779
50. Tashiro, K; Asakura, T; Fujiwara, C; Ohkawa, K; Ishibashi, Y
    Glutathione-S-transferase-pi expression regulates sensitivity to glutathione-doxorubicin conjugate
    ANTI-CANCER DRUGS
    
    K. Tashiro et al., "Glutathione-S-transferase-pi expression regulates sensitivity to glutathione-doxorubicin conjugate", ANTI-CANC D, 12(8), 2001, pp. 707-712
51. Hashizume, Y; Asakura, T; Oikawa, T; Yamauchi, T; Soda, K; Ohkawa, K
    Relationship between cytocidal activity and glutathione-S-transferase inhibition using doxorubicin coupled to stereoisomers of glutathione with different substrate specificity
    ANTI-CANCER DRUGS
    
    Y. Hashizume et al., "Relationship between cytocidal activity and glutathione-S-transferase inhibition using doxorubicin coupled to stereoisomers of glutathione with different substrate specificity", ANTI-CANC D, 12(6), 2001, pp. 549-554
52. Grandjean, F; Bremaud, L; Verdier, M; Robert, J; Ratinaud, MH
    Sequential gene expression of P-glycoprotein (P-gp), multidrug resistance-associated protein (MRP) and lung resistance protein: functional activity of P-gp and MRP present in the doxorubicin-resistant human K562 cell lines
    ANTI-CANCER DRUGS
    
    F. Grandjean et al., "Sequential gene expression of P-glycoprotein (P-gp), multidrug resistance-associated protein (MRP) and lung resistance protein: functional activity of P-gp and MRP present in the doxorubicin-resistant human K562 cell lines", ANTI-CANC D, 12(3), 2001, pp. 247-258
53. Mazel, M; Clair, P; Rousselle, C; Vidal, P; Scherrmann, JM; Mathieu, D; Temsamani, J
    Doxorubicin-peptide conjugates overcome multidrug resistance
    ANTI-CANCER DRUGS
    
    M. Mazel et al., "Doxorubicin-peptide conjugates overcome multidrug resistance", ANTI-CANC D, 12(2), 2001, pp. 107-116
54. Henning, T; Brischwein, M; Baumann, W; Ehret, R; Freund, I; Kammerer, R; Lehmann, M; Schwinde, A; Wolf, B
    Approach to a multiparametric sensor-chip-based tumor chemosensitivity assay
    ANTI-CANCER DRUGS
    
    T. Henning et al., "Approach to a multiparametric sensor-chip-based tumor chemosensitivity assay", ANTI-CANC D, 12(1), 2001, pp. 21-32
55. Ochoa-Herrera, JJ; Huertas, JR; Quiles, JL; Mataix, J
    Dietary oils high in oleic acid, but with different non-glyceride contents, have different effects on lipid profiles and peroxidation in rabbit hepatic mitochondria
    JOURNAL OF NUTRITIONAL BIOCHEMISTRY
    
    J.J. Ochoa-Herrera et al., "Dietary oils high in oleic acid, but with different non-glyceride contents, have different effects on lipid profiles and peroxidation in rabbit hepatic mitochondria", J NUTR BIOC, 12(6), 2001, pp. 357-364
56. Nousiainen, T; Vanninen, E; Jantunen, E; Puustinen, J; Remes, J; Rantala, A; Hartikainen, J
    Comparison of echocardiography and radionuclide ventriculography in the follow-up of left ventricular systolic function in adult lymphoma patients during doxorubicin therapy
    JOURNAL OF INTERNAL MEDICINE
    
    T. Nousiainen et al., "Comparison of echocardiography and radionuclide ventriculography in the follow-up of left ventricular systolic function in adult lymphoma patients during doxorubicin therapy", J INTERN M, 249(4), 2001, pp. 297-303
57. Hrelia, S; Bordoni, A; Biagi, PL
    Role of gamma-linolenic acid in counteracting doxorubicin induced damage in cultured rat cardiomyocytes
    PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS
    
    S. Hrelia et al., "Role of gamma-linolenic acid in counteracting doxorubicin induced damage in cultured rat cardiomyocytes", PROS LEUK E, 64(3), 2001, pp. 139-145
58. Bean, LJH; Stark, GR
    Phosphorylation of serines 15 and 37 is necessary for efficient accumulation of p53 following irradiation with UV
    ONCOGENE
    
    L.J.H. Bean e G.R. Stark, "Phosphorylation of serines 15 and 37 is necessary for efficient accumulation of p53 following irradiation with UV", ONCOGENE, 20(9), 2001, pp. 1076-1084
59. Stewart, ZA; Tang, LJ; Pietenpol, JA
    Increased p53 phosphorylation after microtubule disruption is mediated in a microtubule inhibitor- and cell-specific manner
    ONCOGENE
    
    Z.A. Stewart et al., "Increased p53 phosphorylation after microtubule disruption is mediated in a microtubule inhibitor- and cell-specific manner", ONCOGENE, 20(1), 2001, pp. 113-124
60. Shirafuji, T; Oka, T; Sawada, T; Tamura, K; Kishimoto, K; Yamamoto, S; Nagayasu, T; Takahashi, T; Ayabe, H
    The importance of peripheral blood leukocytes and macrophage infiltration on bronchial wall wound healing in rats treated preoperatively with anticancer agents
    SURGERY TODAY
    
    T. Shirafuji et al., "The importance of peripheral blood leukocytes and macrophage infiltration on bronchial wall wound healing in rats treated preoperatively with anticancer agents", SURG TODAY, 31(4), 2001, pp. 308-316
61. Sasaki, T; Kusafuka, T; Okada, A
    Analysis of the development of normal foregut and tracheoesophageal fistula in an adriamycin rat model using three-dimensional image reconstruction
    SURGERY TODAY-THE JAPANESE JOURNAL OF SURGERY
    
    T. Sasaki et al., "Analysis of the development of normal foregut and tracheoesophageal fistula in an adriamycin rat model using three-dimensional image reconstruction", SURG TODAY, 31(2), 2001, pp. 133-139
62. Alnabari, M; Bittner, S
    New quinone-amino acid conjugates linked via a vinylic spacer
    AMINO ACIDS
    
    M. Alnabari e S. Bittner, "New quinone-amino acid conjugates linked via a vinylic spacer", AMINO ACIDS, 20(4), 2001, pp. 381-387
63. Gorohovsky, S; Bittner, S
    Novel N-quinonyl amino acids and their transformation to 3-substituted p-isoxazinones
    AMINO ACIDS
    
    S. Gorohovsky e S. Bittner, "Novel N-quinonyl amino acids and their transformation to 3-substituted p-isoxazinones", AMINO ACIDS, 20(2), 2001, pp. 135-144
64. Ozen, S; Usta, Y; Sahin-Erdemli, I; Orhan, D; Gumusel, B; Yang, B; Gursoy, Y; Tulunay, O; Dalkara, T; Bakkaloglu, A; El-Nahas, M
    Association of nitric oxide production and apoptosis in a model of experimental nephropathy
    NEPHROLOGY DIALYSIS TRANSPLANTATION
    
    S. Ozen et al., "Association of nitric oxide production and apoptosis in a model of experimental nephropathy", NEPH DIAL T, 16(1), 2001, pp. 32-38
65. Deman, A; Ceyssens, B; Pauwels, M; Zhang, JG; Vanden Houte, K; Verbeelen, D; Van den Branden, C
    Altered antioxidant defence in a mouse adriamycin model of glomerulosclerosis
    NEPHROLOGY DIALYSIS TRANSPLANTATION
    
    A. Deman et al., "Altered antioxidant defence in a mouse adriamycin model of glomerulosclerosis", NEPH DIAL T, 16(1), 2001, pp. 147-150
66. Taatjes, DJ; Koch, TH
    Nuclear targeting and retention of anthracycline antitumor drugs in sensitive and resistant tumor cells
    CURRENT MEDICINAL CHEMISTRY
    
    D.J. Taatjes e T.H. Koch, "Nuclear targeting and retention of anthracycline antitumor drugs in sensitive and resistant tumor cells", CURR MED CH, 8(1), 2001, pp. 15-29
67. Yang, HL; Dong, YB; Elliott, MJ; Wong, SL; McMasters, KM
    Additive effect of adenovirus-mediated E2F-1 gene transfer and topoisomerase II inhibitors on apoptosis in human osteosarcoma cells
    CANCER GENE THERAPY
    
    H.L. Yang et al., "Additive effect of adenovirus-mediated E2F-1 gene transfer and topoisomerase II inhibitors on apoptosis in human osteosarcoma cells", CANC GENE T, 8(4), 2001, pp. 241-251
68. Gianni, L; Dombernowsky, P; Sledge, G; Martin, M; Amadori, D; Arbuck, SG; Ravdin, P; Brown, M; Messina, M; Tuck, D; Weil, C; Winograd, B
    Cardiac function following combination therapy with paclitaxel and doxorubicin: An analysis of 657 women with advanced breast cancer
    ANNALS OF ONCOLOGY
    
    L. Gianni et al., "Cardiac function following combination therapy with paclitaxel and doxorubicin: An analysis of 657 women with advanced breast cancer", ANN ONCOL, 12(8), 2001, pp. 1067-1073
69. Dazzi, H; Kaufmann, K; Follath, F
    Anthracycline-induced acute cardiotoxicity in adults treated for leukaemia- Analysis of the clinico-pathological aspects of documented acute anthracycline-induced cardiotoxicity inpatients treated for acute leukaemia at theUniversity Hospital of Zurich, Switzerland, between 1990 and 1996
    ANNALS OF ONCOLOGY
    
    H. Dazzi et al., "Anthracycline-induced acute cardiotoxicity in adults treated for leukaemia- Analysis of the clinico-pathological aspects of documented acute anthracycline-induced cardiotoxicity inpatients treated for acute leukaemia at theUniversity Hospital of Zurich, Switzerland, between 1990 and 1996", ANN ONCOL, 12(7), 2001, pp. 963-966
70. Icli, F; Akbulut, H; Dincol, D; Onur, H; Demirkazik, A; Cam, R; Cay, F; Demirci, S; Uner, A; Erekul, S
    A randomized trial of four cycles of adjuvant AC (adriamycin plus cyclophosphamide) +/- two cycles of EP (etoposide plus cisplatin) in node positive patients with breast cancer
    ANNALS OF ONCOLOGY
    
    F. Icli et al., "A randomized trial of four cycles of adjuvant AC (adriamycin plus cyclophosphamide) +/- two cycles of EP (etoposide plus cisplatin) in node positive patients with breast cancer", ANN ONCOL, 12(7), 2001, pp. 1011-1013
71. Gebbia, V; Testa, A; Borsellino, N; Ferrera, P; Tirrito, M; Palmeri, S
    Cisplatin and vinorelbine in advanced and/or metastatic adenocarcinoma of the endometrium: A new highly active chemotherapeutic regimen
    ANNALS OF ONCOLOGY
    
    V. Gebbia et al., "Cisplatin and vinorelbine in advanced and/or metastatic adenocarcinoma of the endometrium: A new highly active chemotherapeutic regimen", ANN ONCOL, 12(6), 2001, pp. 767-772
72. Szelenyi, H; Kreuser, ED; Keilholz, U; Menssen, HD; Keitel-Wittig, C; Siehl, J; Knauf, W; Thiel, E
    Cyclophosphamide, adriamycin and dexamethasone (CAD) is a highly effectivetherapy for patients with advanced multiple myeloma
    ANNALS OF ONCOLOGY
    
    H. Szelenyi et al., "Cyclophosphamide, adriamycin and dexamethasone (CAD) is a highly effectivetherapy for patients with advanced multiple myeloma", ANN ONCOL, 12(1), 2001, pp. 105-108
73. Korac, B; Buzadzic, B
    Doxorubicin toxicity to the skin: possibility of protection with antioxidants enriched yeast
    JOURNAL OF DERMATOLOGICAL SCIENCE
    
    B. Korac e B. Buzadzic, "Doxorubicin toxicity to the skin: possibility of protection with antioxidants enriched yeast", J DERMA SCI, 25(1), 2001, pp. 45-52
74. Joyeux, M; Godin-Ribuot, D; Faure, P; Demenge, P; Ribuot, C
    Heat stress protects against electrophysiological damages induced by acutedoxorubicin exposure in isolated rat hearts
    CARDIOVASCULAR DRUGS AND THERAPY
    
    M. Joyeux et al., "Heat stress protects against electrophysiological damages induced by acutedoxorubicin exposure in isolated rat hearts", CARDIO DRUG, 15(3), 2001, pp. 219-224
75. Kataoka, Y; Ishikawa, M; Miura, M; Takeshita, M; Fujita, R; Furusawa, S; Takayanagi, M; Takayanagi, Y; Sasaki, K
    Reversal of vinblastine resistance in human leukemic cells by haloperidol and dihydrohaloperidol
    BIOLOGICAL & PHARMACEUTICAL BULLETIN
    
    Y. Kataoka et al., "Reversal of vinblastine resistance in human leukemic cells by haloperidol and dihydrohaloperidol", BIOL PHAR B, 24(6), 2001, pp. 612-617
76. Furusawa, S; Kimura, E; Kisara, S; Nakano, S; Murata, R; Tanaka, Y; Sakaguchi, S; Takayanagi, M; Takayanagi, Y; Sasaki, K
    Mechanism of resistance to oxidative stress in doxorubicin resistant cells
    BIOLOGICAL & PHARMACEUTICAL BULLETIN
    
    S. Furusawa et al., "Mechanism of resistance to oxidative stress in doxorubicin resistant cells", BIOL PHAR B, 24(5), 2001, pp. 474-479
77. Sugahara, S; Okuno, S; Yano, T; Hamana, H; Inoue, K
    Characteristics of tissue distribution of various polysaccharides as drug carriers: Influences of molecular weight and anionic charge on tumor targeting
    BIOLOGICAL & PHARMACEUTICAL BULLETIN
    
    S. Sugahara et al., "Characteristics of tissue distribution of various polysaccharides as drug carriers: Influences of molecular weight and anionic charge on tumor targeting", BIOL PHAR B, 24(5), 2001, pp. 535-543
78. Tanaka, T; Fujishima, Y; Kaneo, Y
    Receptor mediated endocytosis and cytotoxicity of transferrin-mitomycin c conjugate in the HepG2 cell and primary cultured rat hepatocyte
    BIOLOGICAL & PHARMACEUTICAL BULLETIN
    
    T. Tanaka et al., "Receptor mediated endocytosis and cytotoxicity of transferrin-mitomycin c conjugate in the HepG2 cell and primary cultured rat hepatocyte", BIOL PHAR B, 24(3), 2001, pp. 268-273
79. Hattori, K; Matsushita, R; Kimura, K; Abe, Y; Nakashima, E
    Synergistic effect of indomethacin with adriamycin and cisplatin on tumor growth
    BIOLOGICAL & PHARMACEUTICAL BULLETIN
    
    K. Hattori et al., "Synergistic effect of indomethacin with adriamycin and cisplatin on tumor growth", BIOL PHAR B, 24(10), 2001, pp. 1214-1217
80. Manabe, N; Kinoshita, A; Yamaguchi, M; Furuya, Y; Nagano, N; Yamada-Uchio, K; Akashi, N; Miyamoto-Kuramitsu, K; Miyamoto, H
    Changes in quantitative profile of extracellular matrix components in the kidneys of rats with adriamycin-induced nephropathy
    JOURNAL OF VETERINARY MEDICAL SCIENCE
    
    N. Manabe et al., "Changes in quantitative profile of extracellular matrix components in the kidneys of rats with adriamycin-induced nephropathy", J VET MED S, 63(2), 2001, pp. 125-133
81. Nokihara, H; Yano, S; Nishioka, Y; Hanibuchi, M; Higasida, T; Tsuruo, T; Sone, S
    A new quinoline derivative MS-209 reverses multidrug resistance and inhibits multiorgan metastases by P-glycoprotein-expressing human small cell lungcancer cells
    JAPANESE JOURNAL OF CANCER RESEARCH
    
    H. Nokihara et al., "A new quinoline derivative MS-209 reverses multidrug resistance and inhibits multiorgan metastases by P-glycoprotein-expressing human small cell lungcancer cells", JPN J CANC, 92(7), 2001, pp. 785-792
82. Kurosawa, K; Takahashi, K; Tsuda, E; Tomida, A; Tsuruo, T
    Reversal of multidrug resistance by novel nitrophenyl pyrones, SNF4435C and D
    JAPANESE JOURNAL OF CANCER RESEARCH
    
    K. Kurosawa et al., "Reversal of multidrug resistance by novel nitrophenyl pyrones, SNF4435C and D", JPN J CANC, 92(11), 2001, pp. 1235-1241
83. Uchiyama-Kokubu, N; Watanabe, T; Cohen, D
    Intracellular levels of two cyclosporin derivatives valspodar (PSC 833) and cyclosporin a closely associated with multidrug resistance-modulating activity in sublines of human colorectal adenocarcinoma HCT-15
    JAPANESE JOURNAL OF CANCER RESEARCH
    
    N. Uchiyama-Kokubu et al., "Intracellular levels of two cyclosporin derivatives valspodar (PSC 833) and cyclosporin a closely associated with multidrug resistance-modulating activity in sublines of human colorectal adenocarcinoma HCT-15", JPN J CANC, 92(10), 2001, pp. 1116-1126
84. Sayed-Ahmed, MM; Khattab, MM; Gad, MZ; Osman, AMA
    Increased plasma endothelin-1 and cardiac nitric oxide during doxorubicin-induced cardiomyopathy
    PHARMACOLOGY & TOXICOLOGY
    
    M.M. Sayed-Ahmed et al., "Increased plasma endothelin-1 and cardiac nitric oxide during doxorubicin-induced cardiomyopathy", PHARM TOX, 89(3), 2001, pp. 140-144
85. Whiteman, KR; Subr, V; Ulbrich, K; Torchilin, VP
    Poly(HPMA)-coated liposomes demonstrate prolonged circulation in mice
    JOURNAL OF LIPOSOME RESEARCH
    
    K.R. Whiteman et al., "Poly(HPMA)-coated liposomes demonstrate prolonged circulation in mice", J LIPOS RES, 11(2-3), 2001, pp. 153-164
86. Barclay, BJ; DeHaan, CL; Hennig, UGG; Iavorovska, O; von Borstel, RW; von Borstel, RC
    A rapid assay for mitochondrial DNA damage and respiratory chain inhibition in the yeast Saccharomyces cerevisiae
    ENVIRONMENTAL AND MOLECULAR MUTAGENESIS
    
    B.J. Barclay et al., "A rapid assay for mitochondrial DNA damage and respiratory chain inhibition in the yeast Saccharomyces cerevisiae", ENV MOL MUT, 38(2-3), 2001, pp. 153-158
87. Liu, YY; Han, TY; Giuliano, AE; Cabot, MC
    Ceramide glycosylation potentiates cellular multidrug resistance
    FASEB JOURNAL
    
    Y.Y. Liu et al., "Ceramide glycosylation potentiates cellular multidrug resistance", FASEB J, 15(3), 2001, pp. 719-730
88. Kristal, O; Lana, SE; Ogilvie, GK; Rand, WM; Cotter, SM; Moore, AS
    Single agent chemotherapy with doxorubicin for feline lymphoma: A retrospective study of 19 cases (1994-1997)
    JOURNAL OF VETERINARY INTERNAL MEDICINE
    
    O. Kristal et al., "Single agent chemotherapy with doxorubicin for feline lymphoma: A retrospective study of 19 cases (1994-1997)", J VET INT M, 15(2), 2001, pp. 125-130
89. Van Acker, FAA; Hulshof, JW; Haenen, GRMM; Menge, WMPB; van der Vijgh, WJF; Bast, A
    New synthetic flavonoids as potent protectors against doxorubicin-induced cardiotoxicity
    FREE RADICAL BIOLOGY AND MEDICINE
    
    F.A.A. Van Acker et al., "New synthetic flavonoids as potent protectors against doxorubicin-induced cardiotoxicity", FREE RAD B, 31(1), 2001, pp. 31-37
90. Ryuzo, M; Soares, V
    Effect of mycophenolate mofetil on the progression of adriamycin nephropathy
    RENAL FAILURE
    
    M. Ryuzo e V. Soares, "Effect of mycophenolate mofetil on the progression of adriamycin nephropathy", RENAL FAIL, 23(5), 2001, pp. 611-619
91. Galli, LG; Volpini, RA; Costa, RS; da Silva, CGA; Coimbra, TM
    Tubular cell lesion, albuminuria, and renal albumin handling in rats treated with adriamycin
    RENAL FAILURE
    
    L.G. Galli et al., "Tubular cell lesion, albuminuria, and renal albumin handling in rats treated with adriamycin", RENAL FAIL, 23(5), 2001, pp. 693-703
92. Lord-Fontaine, S; Agostinelli, E; Przybytkowski, E; Averill-Bates, DA
    Amine oxidase, spermine, and hyperthermia induce cytotoxicity in P-glycoprotein overexpressing multidrug resistant Chinese hamster ovary cells
    BIOCHEMISTRY AND CELL BIOLOGY-BIOCHIMIE ET BIOLOGIE CELLULAIRE
    
    S. Lord-Fontaine et al., "Amine oxidase, spermine, and hyperthermia induce cytotoxicity in P-glycoprotein overexpressing multidrug resistant Chinese hamster ovary cells", BIOC CELL B, 79(2), 2001, pp. 165-175
93. Xu, MF; Ho, S; Qian, ZM; Tang, PL
    Melatonin protects against cardiac toxicity of doxorubicin in rat
    JOURNAL OF PINEAL RESEARCH
    
    M.F. Xu et al., "Melatonin protects against cardiac toxicity of doxorubicin in rat", J PINEAL R, 31(4), 2001, pp. 301-307
94. Granzotto, M; Rapozzi, V; Decorti, G; Giraldi, T
    Effects of melatonin on doxorubicin cytotoxicity in sensitive and pleiotropically resistant tumor cells
    JOURNAL OF PINEAL RESEARCH
    
    M. Granzotto et al., "Effects of melatonin on doxorubicin cytotoxicity in sensitive and pleiotropically resistant tumor cells", J PINEAL R, 31(3), 2001, pp. 206-213
95. Montilla, P; Cruz, A; Padillo, FJ; Tunez, I; Gascon, F; Munoz, MC; Gomez, M; Pera, C
    Melatonin versus treatment against extra-hepatic bile vitamin E as protective oxidative stress after duct ligation in rats
    JOURNAL OF PINEAL RESEARCH
    
    P. Montilla et al., "Melatonin versus treatment against extra-hepatic bile vitamin E as protective oxidative stress after duct ligation in rats", J PINEAL R, 31(2), 2001, pp. 138-144
96. Agapito, MT; Antolin, Y; del Brio, MT; Lopez-Burillo, S; Pablos, MI; Recio, JM
    Protective effect of melatonin against adriamycin toxicity in the rat
    JOURNAL OF PINEAL RESEARCH
    
    M.T. Agapito et al., "Protective effect of melatonin against adriamycin toxicity in the rat", J PINEAL R, 31(1), 2001, pp. 23-30
97. Sliva, D; Harvey, K; Mason, R; Lloyd, F; English, D
    Effect of phosphatidic acid on human breast cancer cells exposed to doxorubicin
    CANCER INVESTIGATION
    
    D. Sliva et al., "Effect of phosphatidic acid on human breast cancer cells exposed to doxorubicin", CANCER INV, 19(8), 2001, pp. 783-790
98. Batist, G; Ramakrishnan, G; Rao, CS; Chandrasekharan, A; Gutheil, J; Guthrie, T; Shah, P; Khojasteh, A; Nair, MK; Hoelzer, K; Tkaczuk, K; Park, YC; Lee, LW
    Reduced cardiotoxicity and preserved antitumor efficacy of liposome-encapsulated doxorubicin and cyclophosphamide compared with conventional doxorubicin and cyclophosphamide in a randomized, multicenter trial of metastatic breast cancer
    JOURNAL OF CLINICAL ONCOLOGY
    
    G. Batist et al., "Reduced cardiotoxicity and preserved antitumor efficacy of liposome-encapsulated doxorubicin and cyclophosphamide compared with conventional doxorubicin and cyclophosphamide in a randomized, multicenter trial of metastatic breast cancer", J CL ONCOL, 19(5), 2001, pp. 1444-1454
99. Adenis, A; Bonneterre, J; Bonneterre, ME; Pion, JM; Vanlemmens, L; Gladieff, L; de Lafontan, B; Martel, P; Mihura, J; Roche, H; Gedouin, D; Kerbrat, P; Lesimple, T; Bremond, A; Devaux, Y; Delecroix, V; Fumoleau, P; Maugard-Louboutin, C; Namer, M; Goudier, MJ; Morice, F; Montcuquet, P; Schraub, S; Coudert, B; Fargeot, P; de Gislain, C; Mayer, F; Bastit, P; Chevallier, B; Grandgirard, A; Monnier, A; Sun, X; Clavere, P; Ollivier, JP; Rhein, B; Roullet, B; Datchary, J; Audhuy, B; Barats, JC; Kohser, F; Dides, S; Ramos, R; Cattan, A; Eymard, JC; Pourny, C; Weber, B; de Laroche, G; Pichon, A; Seffert, P; Hayat, M; Zambon, E; Chollet, P; Van Praagh, I
    Benefit of a high-dose epirubicin regimen in adjuvant chemotherapy for node-positive breast cancer patients with poor prognostic factors: 5-year follow-up results of French adjuvant study group 05 randomized trial
    JOURNAL OF CLINICAL ONCOLOGY
    
    A. Adenis et al., "Benefit of a high-dose epirubicin regimen in adjuvant chemotherapy for node-positive breast cancer patients with poor prognostic factors: 5-year follow-up results of French adjuvant study group 05 randomized trial", J CL ONCOL, 19(3), 2001, pp. 602-611
100. Villalona-Calero, MA; Eder, JP; Toppmeyer, DL; Allen, LF; Fram, R; Velagapudi, R; Myers, M; Amato, A; Kagen-Hallet, K; Razvillas, B; Kufe, DW; Von Hoff, DD; Rowinsky, EK
     Phase I and pharmacokinetic study of LU79553, a DNA intercalating bisnaphthalimide, in patients with solid malignancies
     JOURNAL OF CLINICAL ONCOLOGY
     
     M.A. Villalona-Calero et al., "Phase I and pharmacokinetic study of LU79553, a DNA intercalating bisnaphthalimide, in patients with solid malignancies", J CL ONCOL, 19(3), 2001, pp. 857-869